A well-constructed life settlement portfolio diversifies across three axes: policy-level (insured ages, health profiles, face values, carriers), structural (policy types, premium schedules, LE ranges), and timing (staggered expected maturity dates for smoother cash flow). Published academic research from the Wharton School has shown that portfolios with 100+ policies reduce standard deviation of returns by more than 40% compared to portfolios with 10 or fewer policies, through longevity smoothing. Individual investors rarely reach that scale directly, but the principles scale down — even a 5–15 policy portfolio materially outperforms single-policy concentration on risk-adjusted metrics.
Most new investors in this asset class start with a single policy and stop there. That's often a mistake I've watched play out dozens of times. A single life settlement is not an investment strategy — it's a bet on one person's actuarial projection being accurate. The economics of the asset class work through diversification: when you own multiple policies with staggered maturity timelines, spread across carriers and ages and health profiles, the actuarial variance at the individual-policy level smooths out at the portfolio level. This is exactly why institutional investors allocating to life settlement investments build portfolios of 50–500+ policies. Individual investors can't match that scale, but understanding why scale matters will change how you think about single-policy decisions.
Why single-policy concentration is the default mistake
The fundamental insight about life settlement returns is that the projected IRR for any individual policy is a central estimate — the middle of a distribution, not a promise. Even a well-underwritten policy with two independent LE reports that agree within 12 months can have the insured pass meaningfully earlier or later than projected. That's not underwriting failure; that's the inherent variance in mortality-linked outcomes for individual people.
On a single policy, that variance is the entire return. If the baseline projected IRR is 10% and the insured passes three years past projected LE, the realized return could drop to 3–5%. If they pass two years early, the realized return could be 15%+. These are not extreme scenarios — they're within the normal statistical distribution around any individual LE projection. A single-policy investor bears all of that variance with no offsetting mechanism.
Once you add a second policy, an offsetting dynamic appears. If insured #1 lives longer than projected, insured #2 might pass at or slightly before their projected LE — and the portfolio-level return reflects the average of both outcomes, not the worst case of either. Scale that to 10 or 50 or 200 policies, and the statistical variance at the individual-policy level collapses toward the actuarial average at the portfolio level. This is called longevity smoothing, and it's the core mathematical reason life settlements function as a reliable asset class for institutional investors.
The three diversification axes that actually matter
Not all diversification is equal. Simply buying 10 policies that all insure 82-year-old men in the same state issued by the same carrier doesn't actually diversify much — those 10 policies will tend to perform similarly under adverse scenarios. Real diversification in a life settlement portfolio operates across three distinct axes that affect outcomes independently.
Policy-level diversity
- Insured ages. Mix of 68–85 range
- Gender. Male and female insureds
- Health profiles. Different primary impairments
- Carrier concentration. Multiple carriers, A+ rated
- Face value. Mix of small, medium, and larger policies
Structural diversity
- Policy types. Universal life and whole life mix
- Premium schedules. Level vs. escalating premium policies
- Policy age at acquisition. Older vs. newer policies
- LE ranges. Mix of 48–120 month projections
- Purchase price ratio. Varying entry multiples
Timing diversity
- Staggered maturity dates. Spread across 3–10 year horizon
- Cash flow smoothing. Distributions over time, not clustered
- Vintage diversification. Policies acquired at different market cycles
- LE distribution. Avoid clustering of LE projections
- Reinvestment rhythm. Proceeds redeployable periodically
Most single-policy investors automatically get zero of these axes. Small portfolios (3–5 policies) typically get two of them — policy-level and timing — if they were thoughtfully constructed. True structural diversification usually requires 10+ policies and active selection across policy types. For an individual accredited investor, realistic diversification targets depend on your capital commitment. With $500K–$1M committed, you might build a 3–6 policy portfolio covering the most important dimensions. With $3M+, you can approach something closer to what institutions do.
Browse vetted policies to build your portfolio
HYV's marketplace gives accredited investors ongoing access to individual vetted policies across ages, carriers, and LE ranges. Build diversification by acquiring policies over months and years, not all at once.
Browse ListingsHow many policies is enough?
The honest answer depends on what you're solving for. If your goal is to reduce variance to the point where the realized return closely tracks the projected portfolio IRR, the academic research is reasonably clear. If your goal is just to avoid the worst outcomes of single-policy concentration, the threshold is much lower.
Research from the Wharton School has found that life settlement portfolios with 100+ policies exhibit at least 40% lower standard deviation of returns compared to portfolios with 10 or fewer policies. The reduction comes from longevity smoothing — individual-policy mortality variance offsetting across a diversified pool.
Realistic targets for individual investors
Reaching 100 policies is out of reach for most individual accredited investors. Direct ownership of 100 policies would require somewhere between $15M–$30M in capital depending on face values and purchase ratios. What's useful to know is that meaningful diversification benefits appear well before that threshold. The variance reduction curve is non-linear — moving from 1 policy to 5 captures a disproportionate share of the available benefit, while moving from 20 to 100 captures progressively smaller increments.
| Portfolio size | Approx. capital (direct ownership) | Variance profile |
|---|---|---|
| 1 policy | $150K–$300K | High — single insured mortality determines outcome |
| 3–5 policies | $500K–$1.5M | Meaningful reduction from single-policy; significant residual variance |
| 10–15 policies | $1.5M–$4M | Substantial smoothing; realized returns much closer to projections |
| 50+ policies | $7M–$15M | Institutional-style variance profile; approaches portfolio IRR |
| 100+ policies | $15M+ | Reference institutional threshold for longevity smoothing |
For investors who want broader diversification than direct ownership can practically provide, life settlement fund structures are the alternative. A well-run fund might hold 50–500+ policies across multiple sleeves, giving you institutional-scale diversification at a fraction of the direct-ownership capital commitment. The trade-off is management fees, less policy-level transparency, and dependency on the fund manager's decision-making. Neither path is categorically better — they solve different problems.
Variance smoothing — the math in practice
It's one thing to talk about diversification theoretically. It's more useful to see what actually happens to realized returns under concentrated versus diversified construction. The illustration below isn't a forecast — it's a pattern I've watched repeat across investors who pursued each approach.
Single-policy portfolio
10-policy portfolio
The key observation in that illustration isn't the slightly wider upside range in the single-policy case — it's the asymmetry of the downside. A diversified portfolio can have a disappointing year without any single bad outcome wiping out the investor's position. A single-policy portfolio has no such protection. For investors whose life settlement allocation is a meaningful portion of their total portfolio, that asymmetry is often the deciding factor.
Building a portfolio strategy when you're not institutional
Institutional investors building 100+ policy books have the capital to diversify broadly from day one. Individual accredited investors need a different approach — one that builds diversification incrementally over multiple acquisition cycles. Here's the framework I recommend to investors starting with $500K–$5M in committed capital.
- Start with a target portfolio size, not a target policy. Decide upfront whether you're building toward a 3-policy, 10-policy, or larger book over the next 12–24 months. The target shapes every individual acquisition decision — smaller policies become more attractive when you're building breadth, larger policies when you're concentrating.
- Deliberately spread acquisitions over time. Buying five policies in the same month concentrates you in whatever market conditions and pricing existed at that moment. Acquiring over 6–18 months produces vintage diversification and lets you learn from each acquisition before committing to the next.
- Track your diversification axes as you go. Keep a simple spreadsheet of each policy's key characteristics — age, gender, carrier, LE, entry multiple, premium schedule type. When evaluating the next policy, use the spreadsheet to identify where the current portfolio is concentrated and what would best balance it.
- Avoid building the same policy twice. A common mistake is acquiring multiple policies that look similar on paper — similar ages, similar LEs, similar carriers. This feels like a portfolio but functions more like a concentrated position. Deliberately seek acquisitions that differ on at least two of the three diversification axes from your existing holdings.
- Reinvest maturity proceeds deliberately. When policies mature earlier in the portfolio's life, resist the urge to redeploy into whatever looks available immediately. Use maturity proceeds strategically to address gaps in your existing diversification.
See what's available this month on HYV
The HYV platform lists vetted policies on a continuous basis — face values, LE reports, carrier ratings, and transparent pricing — giving accredited investors the ability to build diversified portfolios over time.
Four mistakes that undermine portfolio construction
These are the patterns I've watched first-time portfolio builders repeat most often. Any one of them on its own can undo a significant portion of the diversification benefit you're trying to build.
- Acquiring multiple policies issued by the same carrier. Even A+ rated carriers can be downgraded over long holding periods. Carrier concentration is one of the easiest exposures to eliminate — most investors should cap any single carrier at 25–30% of total face value across their portfolio, regardless of how attractive that carrier's policies look individually.
- Clustering LE projections around a single window. A portfolio where all 8 policies have projected LEs between 60–72 months will tend to mature around the same time, which defeats timing diversification and concentrates reinvestment risk. Deliberately spread LE projections across a wider range (48–120 months where possible).
- Over-weighting by face value rather than by risk contribution. It's tempting to think "I bought 10 policies, so I'm diversified." But if 70% of your capital is in three large-face-value policies and 30% in seven small ones, you're effectively concentrated in the three large positions. Track the percent of total capital (not policy count) exposed to each dimension.
- Ignoring correlation between policies. Two policies on insureds with similar impairments — both with advanced COPD, for example — can have correlated outcomes if medical research produces a treatment breakthrough. Diversify primary impairments across the portfolio, not just ages and carriers.
Published academic research on life settlement portfolio construction and variance smoothing is available through the Wharton School and other institutional research programs. The Geneva Papers on Risk and Insurance has published empirical studies on portfolio efficiency with life settlement allocations. For general alternative investment portfolio construction principles, SEC investor bulletins on alternative investment funds cover relevant concepts applicable across asset classes.
Start building on the HYV marketplace
Every policy listing on HYV gives you the information you need to evaluate how it fits — or doesn't fit — your existing portfolio. Build diversification over time with transparent access to individual vetted policies.
Frequently asked questions
How many life settlement policies should I own to be properly diversified?
The variance reduction from diversification follows a non-linear curve. Moving from 1 policy to 5 policies captures a disproportionate share of the available benefit. Moving from 5 to 15 policies captures substantially more reduction in return variance. Moving from 15 to 100 captures progressively smaller increments. Wharton School research suggests 100+ policies approach the institutional threshold for longevity smoothing with 40%+ reduction in standard deviation compared to 10-policy portfolios. For most individual accredited investors with capital constraints, 5–15 policies represents a practical target that captures most of the available variance reduction without requiring institutional-scale commitment.
Is buying one life settlement policy a reasonable starting point?
It can be, but only if you're planning to build toward a larger portfolio. A single policy as a complete portfolio is not a diversified investment — it's a concentrated position subject to the full variance of individual mortality outcomes. As a first acquisition in a planned 5–10 policy build-out over 12–24 months, a single policy is a reasonable start because it lets you learn the mechanics of the asset class with a smaller capital commitment. But treating one policy as your complete allocation to the asset class exposes you to variance that the economics of life settlements were never designed to absorb.
Can I get diversified exposure without owning policies directly?
Yes. Life settlement fund structures give investors access to portfolios of 50–500+ policies through a single fund investment, providing institutional-scale diversification at a fraction of the direct-ownership capital commitment. The trade-off is management fees, less policy-level transparency, and dependency on the fund manager's decision-making and ongoing operational integrity. Interval funds and registered closed-end funds that hold life settlement portfolios are also available to non-accredited retail investors in some cases. The choice between direct ownership and fund investing depends on capital available, desired level of transparency, and tolerance for fund-level fees.
How do I track diversification across the three axes in practice?
A simple spreadsheet is usually sufficient. For each policy you own, track: insured age and gender, primary health impairment, policy type and carrier, face value, purchase price and purchase-to-face ratio, projected LE and LE underwriters used, and projected maturity year. Each new acquisition should be evaluated against this spreadsheet to identify where your portfolio is concentrated and what dimension would best balance it. Many direct-ownership investors update this spreadsheet after each acquisition and use it during evaluation of the next opportunity. Institutional investors build more sophisticated portfolio-level monitoring tools, but the underlying logic is the same.
What happens when policies in my portfolio mature at different times?
Staggered maturities are actually a benefit of proper timing diversification, not a problem to manage around. When policies mature at different times, you receive distributions across multiple years rather than a single lump sum, which creates smoother cash flow and provides capital for redeployment into new policies. Most institutional life settlement portfolios are designed specifically to produce this laddered maturity structure. The operational aspect — filing claims, collecting death benefits, handling tax reporting — is typically managed by a servicing provider, so the investor experience is that distributions arrive periodically as maturities occur rather than requiring active management each time.
Should I diversify across geographic regions of the U.S.?
Geographic diversity is generally a minor consideration compared to the three main axes (policy-level, structural, timing). Life expectancies for insureds with similar health profiles don't meaningfully differ by geographic region within the U.S. The relevant geographic consideration is jurisdictional — life settlements are regulated at the state level, and buying policies from sellers in different states means coordinating with different licensed providers and different state regulatory frameworks. This is handled by the licensed provider partners rather than the investor directly, but the 43 U.S. states plus Puerto Rico with specific life settlement legislation create a broad opportunity set.
Is there a risk of over-diversification in a life settlement portfolio?
For individual investors, over-diversification in the equity-market sense is rarely a practical concern because the capital required to over-diversify is so substantial. The more relevant concern is cost-inefficient diversification — buying many small positions when the acquisition and servicing costs per policy eat into the diversification benefit. At the institutional level, managing several hundred individual policies has genuine operational overhead that needs to be balanced against marginal variance reduction. Most individual investors are nowhere near that trade-off point; building toward 5–15 policies over time produces substantial variance reduction benefit without meaningful operational burden.
